Guizhou Sanli Pharmaceutical Co.,Ltd (SHA:603439)
China · Delayed Price · Currency is CNY 11.55
-0.37 (-3.10%)
Sep 10, 2026, 1:15 PM CST
SHA:603439 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 309.04 | 389.69 | 476.07 | 571.37 | 570.88 | 544.22 |
Trading Asset Securities | 3.01 | 19.93 | 22.95 | 51.5 | 59.91 | 98 |
Cash & Short-Term Investments | 312.04 | 409.61 | 499.02 | 622.87 | 630.79 | 642.22 |
Cash Growth | 2.97% | -17.92% | -19.89% | -1.26% | -1.78% | 10.72% |
Accounts Receivable | 680.02 | 858.34 | 932.12 | 682.86 | 432.82 | 312.8 |
Other Receivables | 4.03 | -0.38 | 2.53 | 3.32 | 2.18 | 51.41 |
Receivables | 684.05 | 857.95 | 934.65 | 686.18 | 435.01 | 364.21 |
Inventory | 227.62 | 222.42 | 320.72 | 175.72 | 98.08 | 88.57 |
Other Current Assets | 41.4 | 39.6 | 43.59 | 8.69 | 8.18 | 4.55 |
Total Current Assets | 1,265 | 1,530 | 1,798 | 1,493 | 1,172 | 1,100 |
Property, Plant & Equipment | 538.35 | 545.57 | 585.15 | 615.13 | 237.4 | 157.91 |
Long-Term Investments | 89.22 | 89.6 | 22.55 | 10.08 | 129.77 | 119.13 |
Goodwill | 432.63 | 432.63 | 554.61 | 554.61 | 161.66 | - |
Other Intangible Assets | 186.79 | 194.28 | 216.13 | 235.23 | 107.3 | 20.38 |
Long-Term Deferred Tax Assets | 13.79 | 15.79 | 15.13 | 11.08 | 6.89 | 5.12 |
Long-Term Deferred Charges | 1.24 | 0.66 | 0.56 | 0.86 | 1.54 | 2.9 |
Other Long-Term Assets | 39.1 | 39.81 | - | - | - | - |
Total Assets | 2,566 | 2,848 | 3,192 | 2,920 | 1,817 | 1,405 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 75.56 | 101.11 | 342.73 | 247.98 | 165.26 | 98.84 |
Accrued Expenses | 15.58 | 78.68 | 67.33 | 39.48 | 31.33 | 16.59 |
Short-Term Debt | 427.04 | 548.67 | 351.52 | 255.32 | 205 | 200 |
Current Portion of Long-Term Debt | 60 | 59.8 | 45.15 | 45.22 | - | - |
Current Portion of Leases | - | 0.11 | 0.5 | 0.15 | 0.5 | - |
Current Income Taxes Payable | 8.84 | 10.51 | 13.84 | 12.77 | 10.91 | 9.4 |
Current Unearned Revenue | 7.66 | 5.47 | 7.79 | 8.17 | 78.96 | 5.83 |
Other Current Liabilities | 143.24 | 232.82 | 405.59 | 229.92 | 56.72 | 29.76 |
Total Current Liabilities | 737.91 | 1,037 | 1,234 | 839.01 | 548.68 | 360.42 |
Long-Term Debt | 149.6 | 149.72 | 209.3 | 254.15 | - | - |
Long-Term Leases | 0.05 | 0.03 | 0.21 | 0.17 | 0.17 | - |
Long-Term Unearned Revenue | 37.05 | 39.19 | 42.97 | 35.97 | 12.5 | 12.5 |
Long-Term Deferred Tax Liabilities | 20.19 | 21.99 | 25.5 | 28.88 | 6.94 | - |
Other Long-Term Liabilities | 87.19 | 87.59 | 85.04 | 52.92 | 10.1 | - |
Total Liabilities | 1,032 | 1,336 | 1,597 | 1,211 | 578.4 | 372.93 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 408.93 | 408.93 | 409.8 | 409.86 | 410.86 | 410.86 |
Additional Paid-In Capital | 159.79 | 153.26 | 149.04 | 225.12 | 229.69 | 223.39 |
Retained Earnings | 992.93 | 977.75 | 1,069 | 876.75 | 625.04 | 423.75 |
Treasury Stock | -94.35 | -94.35 | -100.64 | -41.43 | -26.55 | -26.55 |
Total Common Equity | 1,467 | 1,446 | 1,527 | 1,470 | 1,239 | 1,031 |
Minority Interest | 66.93 | 66.63 | 67.29 | 239.04 | -0.82 | 0.61 |
Shareholders' Equity | 1,534 | 1,512 | 1,595 | 1,709 | 1,238 | 1,032 |
Total Liabilities & Equity | 2,566 | 2,848 | 3,192 | 2,920 | 1,817 | 1,405 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 636.69 | 758.32 | 606.68 | 555.02 | 205.67 | 200 |
Net Cash (Debt) | -324.64 | -348.71 | -107.67 | 67.86 | 425.12 | 442.22 |
Net Cash Growth | - | - | - | -84.04% | -3.87% | 16.36% |
Net Cash Per Share | -0.77 | -0.83 | -0.26 | 0.16 | 1.03 | 1.07 |
Filing Date Shares Outstanding | 422.5 | 404.74 | 405.61 | 408.25 | 410.86 | 410.86 |
Total Common Shares Outstanding | 422.5 | 404.74 | 405.61 | 408.25 | 410.86 | 410.86 |
Working Capital | 527.21 | 492.42 | 563.53 | 654.46 | 623.38 | 739.12 |
Book Value Per Share | 3.47 | 3.57 | 3.77 | 3.60 | 3.02 | 2.51 |
Tangible Book Value | 847.89 | 818.69 | 756.61 | 680.48 | 970.09 | 1,011 |
Tangible Book Value Per Share | 2.01 | 2.02 | 1.87 | 1.67 | 2.36 | 2.46 |
Buildings | - | 502.56 | 543.28 | 549.09 | 181.14 | 152.85 |
Machinery | - | 352.81 | 351.45 | 344.91 | 103.27 | 58.44 |
Construction In Progress | - | - | - | 0.04 | 48.59 | 4.17 |